GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx cash
Cash and short-term investments held at the end of each period.
GeneDx's cash was $132.55M at Jun 30, 2026. For fiscal 2025 it was $171.28M, up 20.5% from the year before. The highest annual figure on record is $401.47M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $171.28M | +20.5% |
| FY2024 | Dec 31, 2024 | $142.18M | +8.4% |
| FY2023 | Dec 31, 2023 | $131.14M | +5.8% |
| FY2022 | Dec 31, 2022 | $123.90M | -69.1% |
| FY2021 | Dec 31, 2021 | $401.47M | +271.3% |
| FY2020 | Dec 31, 2020 | $108.13M | -6.0% |
| FY2019 | Dec 31, 2019 | $115.01M | +9662.8% |
| FY2018 | Dec 31, 2018 | $1.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $132.55M | -2.2% |
| Q1 FY2026 | Mar 31, 2026 | $170.69M | +6.6% |
| Q4 FY2025 | Dec 31, 2025 | $171.28M | +20.5% |
| Q3 FY2025 | Sep 30, 2025 | $155.08M | +32.0% |
| Q2 FY2025 | Jun 30, 2025 | $135.55M | +25.7% |
| Q1 FY2025 | Mar 31, 2025 | $160.15M | +40.6% |
| Q4 FY2024 | Dec 31, 2024 | $142.18M | +8.4% |
| Q3 FY2024 | Sep 30, 2024 | $117.45M | +2.8% |
| Q2 FY2024 | Jun 30, 2024 | $107.85M | -31.5% |
| Q1 FY2024 | Mar 31, 2024 | $113.90M | -47.0% |
| Q4 FY2023 | Dec 31, 2023 | $131.14M | +5.8% |
| Q3 FY2023 | Sep 30, 2023 | $114.30M | -44.4% |
| Q2 FY2023 | Jun 30, 2023 | $157.56M | -47.3% |
| Q1 FY2023 | Mar 31, 2023 | $214.94M | -32.0% |
| Q4 FY2022 | Dec 31, 2022 | $123.90M | -69.1% |
| Q3 FY2022 | Sep 30, 2022 | $205.73M | -55.5% |
| Q2 FY2022 | Jun 30, 2022 | $299.02M | +701.0% |
| Q1 FY2022 | Mar 31, 2022 | $315.90M | +354.7% |
| Q4 FY2021 | Dec 31, 2021 | $401.47M | +271.3% |
| Q3 FY2021 | Sep 30, 2021 | $462.18M | +230.9% |
| Q2 FY2021 | Jun 30, 2021 | $37.33M | -67.5% |
| Q1 FY2021 | Mar 31, 2021 | $69.48M | +5798.1% |
| Q4 FY2020 | Dec 31, 2020 | $108.13M | – |
| Q3 FY2020 | Sep 30, 2020 | $139.68M | – |
| Q4 FY2019 | Dec 31, 2019 | $115.01M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.18M | – |
See a number that looks wrong?